Charles River acquires Accugenix

Oct 08 2012

Drug Discovery News

Charles River's aquisition of Accugenix is the first step to the broader strategy of becoming the premier provider of rapid microbial and endotoxin detection products and services to the biopharmaceutical industry.

Click here to read more about the acquisition.